Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community.
Discover more
Each of us plays a unique role in bringing our purpose to life.
We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Explore Career Opportunities
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
Read the Press ReleasePress release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
Read the Press ReleasePress Release: Online availability of Sanofi’s half-year financial report for 2025
Read the Press ReleasePress Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
Read the Press Release
